| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |